Physician profile
William P Roman
NPI 1760442271
$1,451.02
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $98.98 · 2021: $237 · 2022: $475 · 2023: $207 · 2024: $48.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $278.60 | 2020-2024 | Grafix Pl, Grafix |
| Kerecis Limited | $156.99 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $141.78 | 2021 | |
| Wright Medical Technology, INC. | $134.48 | 2019 | |
| Royal Biologics, INC. | $119.39 | 2019 | |
| Angiodynamics, INC. | $107.22 | 2022 | |
| Sandoz INC. | $82.22 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $50.34 | 2020-2022 | |
| Collaborative Care Diagnostics, LLC | $47.99 | 2022 | |
| Horizon Therapeutics Plc | $33.68 | 2022-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $32.78 | 2022-2023 | Nuzyra |
| Integra Lifesciences Corporation | $28.51 | 2020 | |
| Triad Life Sciences INC. | $26.79 | 2022 | |
| Hartmann USA, INC. | $23.33 | 2022 | |
| Osteomed LLC | $20.68 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20.36 | 2023 | Easyfuse |
| Bioventus LLC | $19.85 | 2022 | |
| Orthofix Medical, INC. | $19.15 | 2023 | Physio-Stim |
| Cardiovascular Systems INC. | $16.95 | 2019 | |
| Treace Medical Concepts, INC. | $16.35 | 2023 | |
| Kci USA, INC. | $15.10 | 2022 | |
| Zyla Life Sciences, INC. | $14.87 | 2020 | |
| Merck Sharp & Dohme LLC | $14.77 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.71 | 2022 | |
| Arthrosurface Incorporated | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.